U.S. Stem Cell Inc (USRM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:U.S. Stem Cell Inc (USRM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7446
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal function. The company’s lead product MyoCell, is designed to populate regions of scar tissue within a patient’s heart with autologous muscle cells, or cells from a patient’s body, to improve cardiac function in chronic heart failure patients. Its services includes the development of proprietary cell therapy products based on regenerative medicine and cell therapy training services, cell collection and cell storage services, sale of cell collection and treatment kits for humans and animals, and operation of a cell therapy clinic. U.S. Stem Cell is headquartered in Sunrise, Florida, the US.

U.S. Stem Cell Inc (USRM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
U.S. Stem Cell Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
U.S. Stem Cell Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
U.S. Stem Cell Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
U.S. Stem Cell Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
U.S. Stem Cell Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
U.S. Stem Cell Inc, Medical Equipment, Deal Details 11
Venture Financing 11
U.S. Stem Cell Raises USD0.3 Million in Venture Financing 11
Private Equity 12
General American Capital to Invest up to USD5 Million in US Stem Cell 12
Partnerships 13
Bioheart Extends Licensing Agreement With Airspeed Equity 13
Bioheart Enters Into Licensing Agreement With Ageless Regenerative Institute For Adipose Cell Technology 14
Equity Offering 15
Bioheart to Raise USD3 Million in Private Placement of Shares 15
Bioheart Completes Private Placement Of Shares For US$3 Million 16
Bioheart Completes Private Placement Of Shares 17
Bioheart Announces Private Placement Of Shares For US$2 Million 18
Debt Offering 19
Bioheart Raises USD3 Million in Private Placement of Notes 19
Acquisition 20
Bioheart to Acquire Pavillion Scientific 20
Bioheart to Invest in Ascyrus Medical 21
U.S. Stem Cell Inc – Key Competitors 22
U.S. Stem Cell Inc – Key Employees 23
U.S. Stem Cell Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Aug 08, 2018: USRM posts profitable results for second quarter 2018 25
May 09, 2018: U.S. Stem Cell Reports First Quarter Results 26
Apr 16, 2018: USRM Reports 2017 Financial Results 27
Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company’s History 28
Corporate Communications 29
Sep 11, 2018: USRM hires senior VP of US & international sales 29
Legal and Regulatory 30
Aug 28, 2017: FDA warns US Stem Cell Clinic of significant deviations 30
Product News 31
May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration 31
Other Significant Developments 32
Apr 24, 2018: Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales 32
Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy 33
Aug 28, 2017: U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
U.S. Stem Cell Inc, Medical Equipment, Key Facts, 2017 2
U.S. Stem Cell Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
U.S. Stem Cell Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
U.S. Stem Cell Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
U.S. Stem Cell Inc, Deals By Market, 2012 to YTD 2018 9
U.S. Stem Cell Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
U.S. Stem Cell Raises USD0.3 Million in Venture Financing 11
General American Capital to Invest up to USD5 Million in US Stem Cell 12
Bioheart Extends Licensing Agreement With Airspeed Equity 13
Bioheart Enters Into Licensing Agreement With Ageless Regenerative Institute For Adipose Cell Technology 14
Bioheart to Raise USD3 Million in Private Placement of Shares 15
Bioheart Completes Private Placement Of Shares For US$3 Million 16
Bioheart Completes Private Placement Of Shares 17
Bioheart Announces Private Placement Of Shares For US$2 Million 18
Bioheart Raises USD3 Million in Private Placement of Notes 19
Bioheart to Acquire Pavillion Scientific 20
Bioheart to Invest in Ascyrus Medical 21
U.S. Stem Cell Inc, Key Competitors 22
U.S. Stem Cell Inc, Key Employees 23
U.S. Stem Cell Inc, Joint Venture 24

List of Figures
U.S. Stem Cell Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
U.S. Stem Cell Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
U.S. Stem Cell Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
U.S. Stem Cell Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
U.S. Stem Cell Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[U.S. Stem Cell Inc (USRM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oshkosh Corporation:企業の戦略・SWOT・財務情報
    Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report Summary Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Comision Federal de Electricidad:企業の戦略的SWOT分析
    Comision Federal de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Yamato Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Schroders Plc:企業の戦略・SWOT・財務情報
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CPC Corp:企業の戦略的SWOT分析
    CPC Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • PT Jakarta International Hotels & Development Tbk:企業の戦略・SWOT・財務情報
    PT Jakarta International Hotels & Development Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Jakarta International Hotels & Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Avidity Biosciences LLC (Avidity Biosciences), formerly Avidity NanoMedicines LLC is a biotech company that develops antibody oligonucleotide conjugates (AOCs). The company’s proprietary platform technology has enhanced pharmacokinetic and biodistribution properties that improves the deliver …
  • NuStar Energy L.P.:企業の戦略・SWOT・財務分析
    NuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report Summary NuStar Energy L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • InSphero AG:製薬・医療:M&Aディール及び事業提携情報
    Summary InSphero AG (InSphero) is a biotechnology company that offers production, culture and assessment of organotypic 3D cell culture models. The company’s product portfolio includes microtissues kits, cytotoxicity assay kits, and microtissue spheroids, among others. Its patented 3D cell culture p …
  • Olvi plc:企業の戦略・SWOT・財務情報
    Olvi plc - Strategy, SWOT and Corporate Finance Report Summary Olvi plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Green Plains Inc (GPRE):企業の財務・戦略的SWOT分析
    Green Plains Inc (GPRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nanion Technologies GmbH-医療機器分野:企業M&A・提携分析
    Summary Nanion Technologies GmbH (Nanion) is a biotechnology company that develops new innovations in the field of ion channel research and screening. The company offers products such as port-a-patch, patchliner, syncropatch 96, syncropatch 384pe, npc-chips, vesicle prep pro, ordering information, s …
  • Stem Inc:電力:M&Aディール及び事業提携情報
    Summary Stem, Inc. (Stem) is a provider of energy storage solutions and software to businesses for managing energy costs. It leverages big data, predictive analytics, cloud computing, and advanced energy storage to reduce peak electrical usage, lower electric bills, and eliminate the need for new ge …
  • Primary Health Care Ltd (PRY):企業の財務・戦略的SWOT分析
    Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Austevoll Seafood Asa
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Oaktree Capital Group Llc:企業の戦略・SWOT・財務分析
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aviragen Therapeutics Inc (AVIR):企業の財務・戦略的SWOT分析
    Aviragen Therapeutics Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kaiser Foundation Health Plan Inc:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Luzhou Bio-chem Technology Limited:企業の戦略・SWOT・財務分析
    Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report Summary Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆